Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 2
2007 7
2008 6
2009 5
2010 3
2012 2
2013 2
2014 6
2015 7
2016 8
2017 5
2018 5
2019 8
2020 7
2021 1
2022 5
2023 9
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Results by year

Filters applied: . Clear all
Page 1
Clinicopathologic Features And Efficacy Of Induction Chemotherapy In Nasopharyngeal Carcinoma: Real-World Experience.
Majidova N, Sari M, Kahvecıglu FA, Ozcan E, Akdag MO, Dogan A, Yıldırım S, Sonusen SD, Yunusov E, Yasar A, Celebi A, Sever N, Kocaaslan E, Erel P, Agyol Y, Guren AK, Arikan R, Işık S, Balvan O, Geredeli C, Uygun K, Hacıbekiroğlu I, Kostek O, Bayoğlu İV. Majidova N, et al. Among authors: sari m. Oncol Res Treat. 2024 Apr 2. doi: 10.1159/000537988. Online ahead of print. Oncol Res Treat. 2024. PMID: 38565096
The Effectiveness of Adjuvant PD-1 Inhibitors in Patients With Surgically Resected Stage III/IV Acral Melanoma.
Arak H, Erkiliç S, Yaslikaya Ş, Eylemer Mocan E, Aktaş G, Özdemir M, Semiz HS, Kiliçkap S, Özalp FR, Sever ÖN, Akdağ G, Ağaoğlu AB, Özçelik M, Sari M, Arcagök M, Anik H, Yayla ŞB, Sever N, Açar FP, Bayrakçi İ, Turhal S, Ayhan M, Kuş T; Turkish Oncology Group Study. Arak H, et al. Among authors: sari m. J Immunother. 2024 Jun 1;47(5):182-189. doi: 10.1097/CJI.0000000000000508. Epub 2024 Mar 11. J Immunother. 2024. PMID: 38333962 Free PMC article.
The prognostic factors in patients with advanced hepatocellular carcinoma: impact of treatment sequencing.
Köstek O, Demirel A, Hacıoğlu MB, Tastekin D, Karabulut S, Gündogdu A, Sever N, Ayhan M, Çelebi A, Majidova N, Yaşar A, Ağyol Y, Erel P, Kocaaslan E, Güren AK, Arıkan R, Isık S, Ercelep O, Goksu SS, Alandag C, Bilgetekin İ, Caner B, Sahin AB, Gulmez A, Akagunduz B, Kose F, Kaplan MA, Dogan E, Sakalar T, Guven DC, Gurbuz M, Ergun Y, Karaagac M, Turker S, Ozkul O, Yıldız B, Sahin S, Demiray AG, Sari M, Erdogan B, Hacıbekiroglu İ, Çakmak Öksüzoğlu ÖB, Kilickap S, Bilici A, Bayoglu İV, Topaloglu S, Cicin İ. Köstek O, et al. Among authors: sari m. J Chemother. 2024 Jan 23:1-9. doi: 10.1080/1120009X.2024.2305066. Online ahead of print. J Chemother. 2024. PMID: 38263804
PNI as a Potential Add-On Biomarker to Improve the IMDC Intermediate Prognostic Score.
Bayoğlu İV, Hüseynov J, Topal A, Sever N, Majidova N, Çelebi A, Yaşar A, Arıkan R, Işık S, Hacıoğlu MB, Ercelep Ö, Sarı M, Erdoğan B, Hacıbekiroğlu İ, Topaloğlu S, Köstek O, Çiçin İ. Bayoğlu İV, et al. Among authors: sari m. J Clin Med. 2023 Oct 9;12(19):6420. doi: 10.3390/jcm12196420. J Clin Med. 2023. PMID: 37835062 Free PMC article.
The effect of low HER2 expression on treatment outcomes in metastatic hormone receptor positive breast cancer patients treated with a combination of a CDK4/6 inhibitor and endocrine therapy: A multicentric retrospective study.
Caliskan Yildirim E, Atag E, Coban E, Umit Unal O, Celebi A, Keser M, Uzun M, Keskinkilic M, Tanrikulu Simsek E, Sari M, Yavuzsen T. Caliskan Yildirim E, et al. Among authors: sari m. Breast. 2023 Aug;70:56-62. doi: 10.1016/j.breast.2023.06.006. Epub 2023 Jun 14. Breast. 2023. PMID: 37343321 Free PMC article.
83 results